| |||||||||
We don't have a Bears article about Pfizer (PFE)/Wyeth (WYE) yet.
You could be the first person to write a bearish analysis about Pfizer (PFE)/Wyeth (WYE). As the first editor, you could earn a "Top Contributor" spot if you have an account.
Top 3 Bears Arguments
Wyeth has suffered several regulatory delays on key drugs which throw doubt on the health of its pipeline.
Wyeth is currently facing thousands of cases relating to withdrawn diet and hormone therapy drugs. This huge liability has weighed on the stock and has adversely impacted the company's cash flow.
Although Wyeth has a broad array of drugs in its pipeline, it has limited success in producing highly anticipated drugs highly with blockbuster potential.
| ||||||
|
|
